AM-2201 is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor. It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University.

IUPAC 1-[(5-fluoropentyl)-1H-indol-3-yl]-(naphthalen-1-yl)methanone
CAS NO. 335161-24-5
Synonyms –
Formula C24H22FNO
Purity ≥ 98 %

You cannot copy content of this page